Ihr Broker

  • DAX 0,70
  • EUR/USD 0,50
  • GOLD 0,30

Nur Spreads

Keine Kommission

Jetzt registrieren

CFDs sind komplexe Instrumente und umfassen aufgrund der Hebelfinanzierung ein hohes Risiko, schnell Geld zu verlieren.

SHS Gesellschaft f?r Beteiligungsmanagement mbH, corporate

SHS Gesellschaft f?r Beteiligungsmanagement mbH,

22.04.2021 - 10:33:09

Healthcare investor SHS sells homecare specialist medigroba to L?wenstein Group

and follow us on LinkedIn https://www.linkedin.com/company/shs-gesellschaft-fuer-beteiligungsmanagement-mbh

PR contact: Regine Hujer SHS Gesellschaft f?r Beteiligungsmanagement mbH Bismarckstra?e 12 72072 T?bingentuebingen@shs-capital.eu Norbert Kraascc@shs-capital.eu Phone +49 172 8061014

About medigroba GmbH:

medigroba GmbH was founded in 1975 as a medical wholesaler (medical supplies, diabetes, etc.) in Balingen and started as a family business with 6 employees. In the 1990s, the company specialised as a homecare provider in Baden-W?rttemberg. In 2016, SHS acquired the majority of shares in medigroba GmbH and has since supported the company's growth strategy. The involvement of the former management in the direction of the company and the preservation of the family-like working atmosphere contributed significantly to the motivation of the staff and resulted in above-average growth in the following years. In 2020, medigroba GmbH had locations in BW, NRW, Hesse, RPF and Bavaria. The workforce grew to around 120 employees at the turn of the year. In addition, medigroba was named "Top Employer in Medium-Sized Businesses in 2019 and 2020" by the magazine FOCUS-BUSINESS and Kununu Germany.

medigroba GmbH offers a complete service for supplying patients with aids in care facilities and in the home environment. In addition, products are offered for the facility itself (e.g. hygiene / disinfection). medigroba's range of services is holistically oriented and includes:

Medical technology (ventilation, monitoring, oxygen) Homecare (enteral nutrition, wound care, abdominal stoma, and incontinence) Infusion therapies (parenteral nutrition, pain therapy, antibiotics) Special care for children Rehabilitation aids (wheelchairs, beds, etc.) Hygiene management Other (diabetes, practice supplies, care aids)

medigroba is a member of the medical supply store association Reha Vital and thus has contracts with all relevant health insurance companies. The company maintains its own medical technology workshop for the preparation and repair of the devices and its own delivery service. The medigroba Academy, a certified training centre, trains more than 1,000 nursing staff each year with increasing demand. medigroba's quality management has recently been certified according to DIN EN ISO 13485:2016. Further information: www.medigroba.de

?

About L?wenstein Medical GmbH & Co KG:

The will to provide service, pronounced customer proximity and customer satisfaction, and innovative strength in the development of new technologies in medical technology are the decisive factors that have made L?wenstein Medical a leading medical technology company. L?wenstein Medical's employees in the office and in the field, as well as in numerous branches and sleep respiratory centres, are committed to the health and quality of life of patients with a high level of dedication and identification and great expertise. L?wenstein Medical's range of services is continuously being expanded and extends from intensive care ventilation, neonatology, anaesthesia, sleep therapy, sleep medicine and sleep diagnostics to outpatient ventilation and oxygen supply. L?wenstein Medical is an innovator, manufacturer, and distributor. For this purpose, almost 2000 employees are available in 28 branches and almost 200 sleep respiratory centres in Germany, for the supply of clinics and more than 700,000 patients. In addition, L?wenstein Medical has its own subsidiaries in Austria, Great Britain, France, the Netherlands, Israel, China, Denmark, Belgium, and Switzerland. In partnership with leading global manufacturers, L?wenstein Medical is a pioneer and market leader in new specialist disciplines such as sleep and respiratory medicine. In its Homecare, Sleep Therapy, Ventilation, Neonatology and Anaesthesia divisions, L?wenstein Medical itself has been developing and producing cutting-edge technology "Made in Germany" for the world market for over 30 years and will continue to do so in the future, exporting life-sustaining medical technology for clinics, doctors, and patients to over 100 countries. L?wenstein Medical ensures the health, satisfaction, and quality of life of patients with products and services at the highest level. This is a claim that has been the basis of L?wenstein Medical's success, in the past as well as in the future. Further information: https://hul.de

22.04.2021 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.The issuer is solely responsible for the content of this announcement.The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at www.dgap.de

1187446??22.04.2021?

@ dgap.de